Treatment of Candida Stomatitis (Oral Thrush)
For mild to moderate oral candidiasis, start with topical therapy using clotrimazole troches 10 mg five times daily or nystatin suspension 100,000 U/mL (4-6 mL) four times daily for 7-14 days; for moderate to severe disease, oral fluconazole 100-200 mg daily for 7-14 days is the most effective first-line treatment. 1
First-Line Treatment Selection
Mild Disease:
- Clotrimazole troches 10 mg five times daily for 7-14 days are recommended as first-line topical therapy 1
- Nystatin suspension (100,000 U/mL, 4-6 mL four times daily) or pastilles (200,000 U, 1-2 pastilles 4-5 times daily) for 7-14 days are equally effective alternatives 1, 2
- Miconazole mucoadhesive buccal 50-mg tablet applied once daily for 7-14 days offers convenient once-daily dosing 1
Moderate to Severe Disease:
- Oral fluconazole 100-200 mg daily for 7-14 days is the most effective treatment with strong recommendation and high-quality evidence from the Infectious Diseases Society of America 1
- This systemic approach provides superior efficacy compared to topical agents in more severe presentations 1
Treatment for Refractory or Fluconazole-Resistant Cases
When patients fail initial fluconazole therapy, escalate systematically:
Second-Line Systemic Options:
- Itraconazole oral solution 200 mg daily for 7-14 days achieves 64-80% response rates in fluconazole-refractory cases 1, 3
- Voriconazole 200 mg twice daily (oral or IV) for 14-21 days for resistant infections 1
- Posaconazole suspension 400 mg twice daily demonstrates approximately 75% efficacy in refractory cases 1
Third-Line Options for Severe Refractory Disease:
- Echinocandins are reserved for severe refractory cases: micafungin 150 mg daily, caspofungin (70-mg loading dose, then 50 mg daily), or anidulafungin 200 mg daily 1
- Amphotericin B deoxycholate 0.3-0.7 mg/kg daily is a less preferred alternative due to toxicity 1
Special Clinical Situations
Denture-Related Candidiasis:
- Antifungal therapy alone is insufficient—proper denture hygiene and disinfection of dentures are essential for definitive cure 1
- This combination approach prevents immediate relapse after antifungal completion 1
HIV-Infected Patients:
- Antiretroviral therapy should be optimized whenever possible to reduce recurrent infections 1
- These patients may require more aggressive initial therapy due to impaired immunity 1
- For recurrent infections, suppressive therapy with fluconazole 100-200 mg three times weekly is recommended 1
Patients Unable to Tolerate Oral Medications:
- Parenteral therapy should be used when oral administration is not feasible 1
Critical Treatment Duration and Monitoring
- Continue treatment for the full recommended 7-14 day duration even if symptoms resolve quickly to prevent relapse 1
- Azole-refractory infections are more common in patients with prior azole exposure and severe immunocompromise 1
Important Clinical Pitfalls to Avoid
- Do not obtain oropharyngeal fungal cultures routinely—many individuals have asymptomatic colonization, and treatment decisions should be based on clinical presentation rather than culture results 1
- Treatment frequently does not result in microbiological cure, only clinical resolution 1
- Topical antifungals require long treatment duration and good patient compliance; nystatin and miconazole need extended use to eradicate infection 4
- Miconazole may interact with other medications—assess drug interactions before prescribing 4